Abstract
Background
Pituitary incidentalomas are sellar lesions identified on imaging performed for unrelated reasons. Lesions measuring 1 cm or larger are classified as macroincidentalomas. Pituitary apoplexy is an acute clinical syndrome caused by hemorrhage or infarction within the pituitary gland and may present with headache, ophthalmoplegia, altered consciousness, visual dysfunction, and hypopituitarism.
Case Presentation
A 36-year-old man presented with decreased consciousness after a motor vehicle crash. Noncontrast CT revealed a right parietal epidural hematoma with approximately 5 mm of midline shift and an incidental sellar mass. Emergency craniotomy and hematoma evacuation were performed, after which his Glasgow Coma Scale score improved to 15. Family members reported that left eyelid ptosis had begun 10 days before the crash. Subsequent MRI demonstrated a large heterogeneous sellar-suprasellar mass with T1-hyperintense components compatible with pituitary apoplexy. Endocrine evaluation showed central hypothyroidism, reduced gonadotropins, low prolactin, normal morning cortisol, and low-normal ACTH. Following endocrinology consultation, perioperative hydrocortisone was administered and later tapered. Endoscopic transsphenoidal resection revealed chronic motor oil-like blood and fragmented dark clot within the tumor. Histopathology confirmed a gonadotroph pituitary neuroendocrine tumor with a Ki-67 labeling index below 1%. The left ptosis resolved completely by the 3-month follow-up.
Conclusion
Life-threatening traumatic lesions may coexist with sellar emergencies and obscure their neurological and endocrine manifestations. In this case, pre-injury left ptosis suggested that the sellar process preceded the crash, whereas the role of trauma as a precipitating or aggravating factor could not be established. After stabilization of the traumatic lesion, targeted sellar imaging and early endocrine involvement should be considered when cranial nerve findings or endocrine abnormalities remain unexplained.
Keywords: epidural hematoma, motor vehicle crash, pituitary apoplexy, pituitary macroincidentaloma
Background
Pituitary incidentalomas are increasingly identified because CT and MRI are frequently performed for head trauma, headache, and other unrelated indications.1,2 Incidental pituitary lesions are reported in approximately 10% of MRI examinations in the general population.3 Although most lesions identified in radiologic and autopsy series are microadenomas, clinically detected incidental lesions may include macroadenomas.4 Demographic patterns vary among cohorts, although men are often diagnosed with larger adenomas.5,6
Natural-history studies indicate that many clinically nonfunctioning pituitary incidentalomas remain stable, although enlargement and apoplexy can occur.7 Pituitary apoplexy may present with acute headache, visual impairment, cranial nerve palsies, altered consciousness, and acute hypopituitarism.8,9 In contrast, non-apoplectic macroadenomas may cause gradual hypopituitarism and optic chiasm compression.10,11
We report a patient with a traumatic epidural hematoma requiring emergency evacuation and a coexisting sellar-suprasellar mass with clinical, MRI, and intraoperative findings consistent with pituitary apoplexy. The coexistence of these lesions complicated attribution of the left ptosis and right mydriasis and required prioritization of the immediately life-threatening epidural hematoma before definitive sellar management. Selected comparable cases from the literature are summarized to place this management sequence in context.
Case Presentation
A 36-year-old man presented to the emergency department with decreased consciousness after a motor vehicle crash. On admission, his Glasgow Coma Scale score was E3V2M6. The right upper and lower limbs moved spontaneously. The left upper limb was paralyzed, and the left lower limb was plegic to the extent that could be assessed. Deep tendon reflexes were symmetric and normal (+2). There were no clinical signs of cerebrospinal fluid rhinorrhea or otorrhea.
Pupillary examination revealed a reactive, mid-sized left pupil and a fixed, dilated right pupil. A complete cranial nerve examination was not possible because of limited cooperation. Family members reported a 10-day history of left eyelid ptosis before the crash, which had not been evaluated. Plantar responses were downgoing bilaterally. Initial laboratory testing showed no immediately life-threatening abnormality. Noncontrast CT demonstrated a right parietal epidural hematoma with a maximum thickness of 3 cm and approximately 5 mm of midline shift, requiring urgent evacuation. The same CT showed an incidental sellar mass enlarging the sella and measuring approximately 4.0×2.0 x 2.5 cm.
The patient underwent emergency right parietal craniotomy and epidural hematoma evacuation. Postoperatively, he stabilized and improved to a Glasgow Coma Scale score of 15. Endocrinology was consulted after epidural hematoma evacuation. MRI then showed a large sellar-suprasellar mass consistent with a pituitary macroadenoma, with suprasellar extension compressing the optic chiasm and parasellar extension corresponding to Knosp grade IIIa. Heterogeneous internal signal and T1-hyperintense components suggested intratumoral hemorrhage compatible with pituitary apoplexy (Figure 1).8,12
Figure 1.

(A) Axial noncontrast CT at the skull base shows an iso- to mildly hyperdense sellar lesion with sellar enlargement (arrow). (B) Axial T2-weighted MRI shows a heterogeneous sellar mass with suprasellar extension (arrow). (C) Coronal gadolinium-enhanced T1-weighted MRI shows heterogeneous enhancement and signal within the expansile sellar lesion (arrow). (D) Sagittal T2-weighted MRI shows a sellar-suprasellar mass with heterogeneous signal compatible with apoplexy (arrow).
Serial endocrine measurements during admission showed low TSH with low total T4 and low/low-normal total T3, supporting central hypothyroidism. LH and FSH were reduced, consistent with gonadotropin deficiency; testosterone was not available, so hypogonadotropic hypogonadism could not be confirmed biochemically. Prolactin was low. Morning cortisol remained within the laboratory reference interval (9.5–12.5 µg/dL), whereas ACTH ranged from borderline low to within range (7.1–8.0 pg/mL). Basal GH and IGF-1 were within their respective reference intervals. Serum sodium ranged from 138 to 154 mEq/L, and urine specific gravity ranged from 1.004 to 1.030 during admission. Paired serum and urine osmolality measurements were not available; therefore, the available data were insufficient to determine whether transient diabetes insipidus occurred. Given the acute clinical setting and concern for pituitary apoplexy, hydrocortisone 100 mg every 8 hours was initiated before transsphenoidal surgery after endocrinology consultation, continued during the immediate postoperative period, and subsequently tapered under endocrinology supervision. The serial hormonal results are summarized in Table 1.
Table 1.
Serial Hormonal Profile During Admission
| Hormone | Result During Admission | Reference Range |
|---|---|---|
| Cortisol (8 AM) | 9.5–12.5 µg/dL | 4.82–19.54 µg/dL |
| ACTH (8 AM) | 7.1–8.0 pg/mL | 7.2–46 pg/mL |
| GH (basal) | 0.2–0.6 ng/mL | <3.0 ng/mL |
| IGF-1 | 70.5–211 ng/mL | 69–227 ng/mL |
| TSH | 0.05–0.47 µIU/mL | 0.35–4.94 µIU/mL |
| Total T4 | 3.6–5.4 µg/dL | 4.87–11.72 µg/dL |
| Total T3 | 0.4–0.6 ng/mL | 0.35–1.93 ng/mL |
| LH | 0.1–0.6 mIU/mL | 0.57–12.07 mIU/mL |
| FSH | 0.2–2.6 mIU/mL | Adult male: 0.95–11.95 mIU/mL |
| Prolactin | 1.0–2.1 ng/mL | 3.46–19.4 ng/mL |
Endoscopic endonasal transsphenoidal resection was performed following partial middle turbinectomy/ethmoidectomy and wide sphenoidotomy. On opening the sellar dura, chronic motor oil-like blood and fragmented dark clot, consistent with chronic and subacute hemorrhage, were clearly identified within the tumor. Gross-total tumor removal, including the capsule, was achieved. An intraoperative cerebrospinal fluid leak was repaired with a multilayer underlay fat graft and an overlay vascularized nasoseptal flap reinforced with hemostatic agents. The patient remained intubated and hemodynamically stable and was transferred to the intensive care unit.
Histopathology
Histopathological examination of the resected sellar mass demonstrated a pituitary neuroendocrine tumor composed of uniform cells arranged in micropapillary structures, with round-to-oval nuclei, finely granular chromatin, and moderate eosinophilic cytoplasm. No mitotic activity was identified. Immunohistochemical findings were consistent with a gonadotroph pituitary neuroendocrine tumor (pituitary adenoma), and the Ki-67 (MIB-1) labeling index was below 1%, indicating low proliferative activity. The pathology report did not describe hemorrhage, necrosis, or hemosiderin deposition in the submitted sections.
Postoperative Recovery
Postoperative MRI demonstrated complete tumor removal and decompression of the optic apparatus (Figure 2). The left-sided ptosis persisted after epidural hematoma evacuation and transsphenoidal resection and then resolved completely by the 3-month follow-up (Figure 3). The clinical sequence is summarized in Table 2.
Figure 2.

(A) Postoperative sagittal T2-weighted MRI shows postoperative changes in the sellar region and reduction of the suprasellar component (arrow). (B) Postoperative coronal gadolinium-enhanced T1-weighted MRI shows decompression of the optic apparatus (arrows).
Figure 3.

Clinical photographs showing (A) complete left ptosis before recovery and (B) complete resolution at the 3-month follow-up. The original photographs were obtained as selfies and are horizontally mirrored; therefore, the patient’s affected left eye appears on the right side of the displayed images.
Table 2.
Clinical Timeline
| Time Point | Neurological/Ocular Findings | Investigation or Intervention |
|---|---|---|
| 10 days before the crash | Left eyelid ptosis began; no right ptosis was reported. | No prior evaluation or imaging was available. |
| Emergency admission after motor vehicle crash | Decreased consciousness (GCS E3V2M6); reactive mid-sized left pupil; fixed, dilated right pupil; family confirmed pre-existing left ptosis. | CT showed a right parietal epidural hematoma with approximately 5 mm midline shift and an incidental sellar mass. |
| Emergency operation | Neurological status improved after surgery. | Right parietal craniotomy and epidural hematoma evacuation. |
| Early postoperative assessment | GCS improved to 15; left ptosis persisted; no right ptosis was present. | Endocrinology consultation; serial pituitary testing; hydrocortisone 100 mg every 8 hours was started before sellar surgery. |
| Sellar MRI | Persistent left ptosis. | MRI showed a large heterogeneous sellar-suprasellar mass with T1-hyperintense components. |
| Transsphenoidal surgery | No new right-sided ptosis. | Endoscopic endonasal resection; chronic motor oil-like blood and fragmented dark clot were observed; intraoperative CSF leak was repaired. |
| Histopathology | Not applicable. | Gonadotroph pituitary neuroendocrine tumor; Ki-67 below 1%. The pathology report did not describe hemorrhage, necrosis, or hemosiderin in the submitted sections. |
| Three-month follow-up | Left ptosis resolved completely. | Clinical follow-up photograph. |
Discussion
This case illustrates a time-critical management problem in which a surgical epidural hematoma coexisted with pituitary apoplexy. Epidural hematoma can cause rapid neurological deterioration and herniation and therefore requires immediate evacuation.13 Pituitary apoplexy can likewise cause altered consciousness, cranial nerve palsies, visual dysfunction, and acute endocrine impairment; early endocrine assessment and empirical corticosteroid coverage may be lifesaving.9,12,14 In this patient, epidural hematoma evacuation was prioritized, followed by endocrinology consultation, stress-dose hydrocortisone, sellar MRI, and transsphenoidal decompression. The educational value of the case lies not in either diagnosis alone, but in their uncommon coexistence, competing treatment priorities, discordant ocular findings, and direct operative evidence of hemorrhage despite nonconfirmatory histological sampling.
Selected previously reported cases are summarized in Table 3 to provide clinical context. These reports are heterogeneous single-case observations with variable timing of presentation, endocrine assessment, imaging, operative sequencing, and follow-up. They therefore cannot establish a causal relationship between trauma and apoplexy or define a uniform management algorithm; their value is illustrative and supports individualized treatment according to the immediately life-threatening lesion, neuro-ophthalmological deficits, and endocrine status.
Table 3.
Selected Published Reports Relevant to Trauma-Associated Pituitary Apoplexy and Incidental Sellar Lesions
| Case | Age/Sex | Presentation/Symptoms | Imaging Findings | Hormonal Findings | Associated Pathology | Management | Outcome |
|---|---|---|---|---|---|---|---|
| Dev, 200715 | 40/M | Sudden severe headache, vomiting, acute visual loss | CT/MRI: sellar–suprasellar hemorrhagic mass + basifrontal ICH | Panhypopituitarism | Road traffic accident → apoplexy in occult NFPA + basifrontal ICH | Endonasal TSS; tumor + basifrontal hematoma evacuated | Vision improved, residual hemianopia; hormone replacement continued |
| Ishigaki, 201716 | 66/M | Delayed isolated left CN III palsy (diplopia, ptosis) 4 days post-fall | CT/MRI: hemorrhage with left cavernous sinus compression; sphenoid thickening | Normal hormonal profile | Minor head trauma → apoplexy in incidental NFPA | Endonasal TSS on day 6 | CN III palsy resolved by day 14; no DI or hypopituitarism |
| Noriega-Jalil, 201817 | 46/M | Severe TBI (GCS 8), hypotension; multiple CN deficits; left ptosis/mydriasis | MRI: hemorrhagic macroadenoma 21×42×52 mm with cavernous sinus invasion | Hypocortisolism + central hypothyroidism + hypogonadotropic hypogonadism; prolactin 6213 ng/mL | Post-traumatic apoplexy in macroprolactinoma | Conservative: stabilization + hydrocortisone, levothyroxine, cabergoline | Tumor shrank; prolactin normalized; persistent hypopituitarism on replacement; residual low left visual acuity |
| Morinaga, 201918 | 42/M | Post-trauma CT incidental sellar mass; subtle acromegalic features | MRI: 22-mm enhancing sellar–suprasellar macroadenoma | Elevated GH and IGF-1; other hormones normal | Trauma-associated recognition of functional incidentaloma | Endoscopic TSS resection | Hormones normalized; no recurrence at 24 months |
| Ward, 201819 | 63/M | Closed head trauma; within 48 h developed AMS, fever, tachycardia, hypotension | MRI: hemorrhagic necrotic pituitary mass; sphenoid mucosal thickening | Panhypopituitarism | Closed head injury → apoplexy in known macroadenoma | Steroids + thyroid replacement; urgent endoscopic TSS | Mental status improved; vision returned to baseline |
| Bao, 200720 | 79/M | Severe headache, nausea/vomiting, neck stiffness after fall | CT/MRI: sellar–suprasellar mass + suprasellar SAH; MRA negative | Hypopituitarism | Fall → apoplexy in incidental adenoma complicated by SAH | Conservative treatment | Tumor regressed; well at 18 months |
| Uchiyama, 199921 | 60/F | Severe headache/nausea; rapid bilateral vision loss (delayed) | MRI: dumbbell sellar–suprasellar macroadenoma with fresh intratumoral hemorrhage | Not specified | Fall with occipital fracture → apoplexy in asymptomatic macroadenoma | Hydrocortisone + urgent TSS (12 h) + staged completion TSS | Vision near baseline by 1 week; no chronic hormone replacement reported |
| Uchiyama, 199921 (case 2) | 66/M | Disorientation; at 15 h developed bilateral blurred vision → rapid severe loss + lethargy | CT/MRI: frontal contusion + enlarging sellar tumor with hemorrhage | Not specified | Fall from height with occipital fracture + frontal contusion → apoplexy | Left frontotemporal craniectomy + partial tumor removal | Vision improved; moderate disability at 4 months; tumor regressed |
| Holness, 198322 | 39/M | Immediate severe vision loss; no meningism | CT/angiography: intrasellar/suprasellar hematoma with chiasmal compression; ACA displaced | Mild prolactin elevation; low testosterone | Minor closed head trauma → apoplexy in silent adenoma | Steroids + frontal craniotomy + hematoma drainage; radiotherapy | Partial right eye recovery; no left recovery at 3 months |
Note: This table is an illustrative selection and not a systematic review.
Abbreviations: ACA, anterior cerebral artery; ACTH, adrenocorticotropic hormone; AMS, altered mental status; CN, cranial nerve; CT, computed tomography; CSF, cerebrospinal fluid; DI, diabetes insipidus; FU, follow-up; GCS, Glasgow Coma Scale; GH, growth hormone; ICH, intracerebral hemorrhage; IGF-1, insulin-like growth factor-1; LOC, loss of consciousness; MRA, magnetic resonance angiography; MRI, magnetic resonance imaging; NFPA, non-functioning pituitary adenoma; SAH, subarachnoid hemorrhage; TBI, traumatic brain injury; TSH, thyroid-stimulating hormone; TSS, transsphenoidal surgery; HM, hand-movement vision.
Left ptosis had been present for 10 days before trauma, supporting pre-existing or subacute left cranial nerve III dysfunction related to the sellar lesion or cavernous sinus involvement. Isolated oculomotor palsy with ptosis has been reported in pituitary apoplexy.16,23,24 By contrast, the fixed, dilated right pupil at presentation was more compatible with acute compressive cranial nerve III dysfunction from epidural hematoma-related intracranial mass effect.25,26 A complete neuro-ophthalmological examination was not possible at admission because of limited cooperation; therefore, these anatomical attributions are presented as the most clinically compatible explanations rather than definitive proof.
Head trauma has been reported in temporal association with hemorrhage or infarction in pre-existing pituitary adenomas.15,16,22 However, the current case cannot establish causality. Because left ptosis preceded the crash and no pre-event imaging was available, apoplexy may have preceded the trauma, trauma may have precipitated or aggravated an evolving hemorrhagic event, or the two events may have been coincidental. MRI is the preferred imaging modality when pituitary apoplexy is suspected, but its signal characteristics provide only an approximate estimate of hemorrhage age.8,9,12
The endocrine profile was more consistent with pituitary dysfunction than with stalk-effect hyperprolactinemia. Unlike a stalk-effect pattern, which generally causes increased prolactin,27,28 this patient had low prolactin together with central hypothyroidism and reduced gonadotropins. Because testosterone was unavailable, the gonadal-axis abnormality is described as gonadotropin deficiency rather than confirmed hypogonadotropic hypogonadism. Morning cortisol was within the laboratory reference interval, whereas ACTH was low-normal to borderline low. A single morning cortisol value during acute illness does not fully exclude secondary adrenal insufficiency; therefore, after endocrinology consultation, stress-dose hydrocortisone was administered before surgery and through the immediate postoperative period and was subsequently tapered.9,12,14
The pathology report did not describe hemorrhage, necrosis, or hemosiderin deposition in the submitted sections; however, the operative field contained chronic motor oil-like blood and fragmented dark clot, providing direct evidence of chronic and subacute intratumoral bleeding. Histopathology confirmed a low-proliferative gonadotroph pituitary neuroendocrine tumor with a Ki-67 labeling index below 1%. The discrepancy between the operative and microscopic findings may reflect sampling of nonhemorrhagic tumor fragments and is reported explicitly rather than interpreting the pathological sample as excluding apoplexy.
In trauma patients, sellar-protocol MRI should not delay treatment of an immediately life-threatening intracranial lesion. It should be considered after stabilization when cranial nerve findings, visual symptoms, or endocrine abnormalities are not adequately explained by the traumatic lesion. This selective approach is more practical than routine early sellar MRI for all patients with head trauma.
Conclusions
Coexisting epidural hematoma and pituitary apoplexy can produce overlapping but anatomically distinct neurological signs and competing treatment priorities. In this patient, the life-threatening epidural hematoma required immediate evacuation; persistent pre-injury left ptosis, endocrine abnormalities, sellar MRI findings, and intraoperative chronic/subacute blood subsequently supported pituitary apoplexy in a gonadotroph pituitary neuroendocrine tumor. The temporal relationship to trauma remains uncertain. After stabilization of the traumatic lesion, targeted sellar imaging and early endocrine consultation are appropriate when cranial nerve, visual, or hormonal findings remain unexplained.
Funding Statement
There is no funding to report.
Data Sharing Statement
All data generated or analyzed during this study are included in this published article.
Consent for Publication
Written informed consent was obtained from the patient for publication of the case details and accompanying images.
Disclosure
The authors declare that they have no competing interests.
References
- 1.Constantinescu SM, Maiter D. Pituitary incidentaloma. Presse Med. 2021;50(4):104081. doi: 10.1016/j.lpm.2021.104081 [DOI] [PubMed] [Google Scholar]
- 2.Paschou SA, Vryonidou A, Goulis DG. Pituitary incidentalomas: a guide to assessment, treatment and follow-up. Maturitas. 2016;92:143–8. doi: 10.1016/j.maturitas.2016.08.006 [DOI] [PubMed] [Google Scholar]
- 3.Esquenazi Y, Guinto G, Mercado M. Hypophyseal incidentalomas. Gac Med Mex. 2008;144(1):47–53. [PubMed] [Google Scholar]
- 4.Messerer M, Dubourg J, Raverot G, et al. Non-functioning pituitary macro-incidentalomas benefit from early surgery before becoming symptomatic. Clin Neurol Neurosurg. 2013;115(12):2514–2520. doi: 10.1016/j.clineuro.2013.10.007 [DOI] [PubMed] [Google Scholar]
- 5.Iglesias P, Arcano K, Triviño V, et al. Prevalence, clinical features, and natural history of incidental clinically non-functioning pituitary adenomas. Horm Metab Res. 2017;49(9):654–659. doi: 10.1055/s-0043-115645 [DOI] [PubMed] [Google Scholar]
- 6.McDowell BD, Wallace RB, Carnahan RM, Chrischilles EA, Lynch CF, Schlechte JA. Demographic differences in incidence for pituitary adenoma. Pituitary. 2011;14(1):23–30. doi: 10.1007/s11102-010-0253-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fernández-Balsells MM, Murad MH, Barwise A, et al. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(4):905–912. doi: 10.1210/jc.2010-1054 [DOI] [PubMed] [Google Scholar]
- 8.Boellis A, Di Napoli A, Romano A, Bozzao A. Pituitary apoplexy: an update on clinical and imaging features. Insights Imaging. 2014;5(6):753–762. doi: 10.1007/s13244-014-0362-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wichlińska-Lubińska M, Kozera G. Pituitary apoplexy. Neurol Neurochir Pol. 2019;53(6):413–420. doi: 10.5603/PJNNS.a2019.0054 [DOI] [PubMed] [Google Scholar]
- 10.Constantinescu SM, Duprez T, Fomekong E, Raftopoulos C, Alexopoulou O, Maiter D. Natural history and surgical outcome of incidentally discovered clinically nonfunctioning pituitary macroadenomas. Endocr Connect. 2023;12(12):e230224. doi: 10.1530/EC-23-0224 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Damilano RA, Monteserin NL, Otta CF, Mukdsi JH, Mereshian P, Andrada M. Clinical and evolutionary characteristics of incidental pituitary adenomas: retrospective multicenter study. Medicina. 2023;83(4):514–521. [PubMed] [Google Scholar]
- 12.Donegan D, Erickson D. Revisiting pituitary apoplexy. J Endocr Soc. 2022;6(9):bvac113. doi: 10.1210/jendso/bvac113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Khairat A, Margetis K, Waseem M. Epidural Hematoma. In: StatPearls [Internet]. StatPearls Publishing; 2025. [PubMed] [Google Scholar]
- 14.Baldeweg SE, Vanderpump M, Drake W, et al. Society for endocrinology endocrine emergency guidance: emergency management of pituitary apoplexy in adult patients. Endocr Connect. 2016;5(5):G12–G15. doi: 10.1530/EC-16-0057 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Dev R, Singh SK, Sharma MC, Khetan P, Chugh A. Post-traumatic pituitary apoplexy with contiguous intracerebral hematoma operated through an endonasal route: a case report. Pituitary. 2007;10(3):291–294. doi: 10.1007/s11102-007-0015-0 [DOI] [PubMed] [Google Scholar]
- 16.Ishigaki T, Kitano Y, Nishikawa H, et al. Delayed onset of isolated unilateral oculomotor nerve palsy caused by post-traumatic pituitary apoplexy: a case report. Clin Med Insights Case Rep. 2017;10:1179547617731299. doi: 10.1177/1179547617731299 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Noriega-Jalil AB, Garrido-Mendoza AP, Tenorio-Aparicio C, et al. An unusual initial manifestation of prolactinoma with posttraumatic pituitary apoplexy. AACE Clin Case Rep. 2018;4(1):e39–e44. [Google Scholar]
- 18.Morinaga Y, Abe I, Sakamoto K, et al. Pituitary incidentaloma diagnosed as acromegaly triggered by trauma: a case report. Intractable Rare Dis Res. 2019;8(3):210–213. doi: 10.5582/irdr.2019.01075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ward M, Kamal N, Majmundar N, Baisre-De Leon A, Eloy JA, Liu JK. Post-traumatic pituitary tumor apoplexy after closed head injury: case report and review of the literature. World Neurosurg. 2018;120:331–335. doi: 10.1016/j.wneu.2018.08.238 [DOI] [PubMed] [Google Scholar]
- 20.Bao YJ, Li XG, Jing ZT, Ou SW, Wu AH, Wang YJ. Pituitary apoplexy complicated with subarachnoid hemorrhage caused by incidentaloma following a head injury: case report. Chin Med J. 2007;120(24):2341–2343. doi: 10.1097/00029330-200712020-00043 [DOI] [PubMed] [Google Scholar]
- 21.Uchiyama H, Nishizawa S, Satoh A, Yokoyama T, Uemura K. Post-traumatic pituitary apoplexy: two case reports. Neurol Med Chir. 1999;39(1):36–39. doi: 10.2176/nmc.39.36 [DOI] [PubMed] [Google Scholar]
- 22.Holness RO, Ogundimu FA, Langille RA. Pituitary apoplexy following closed head trauma: case report. J Neurosurg. 1983;59(4):677–679. doi: 10.3171/jns.1983.59.4.0677 [DOI] [PubMed] [Google Scholar]
- 23.Cho WJ, Joo SP, Kim TS, Seo BR. Pituitary apoplexy presenting as isolated third cranial nerve palsy with ptosis: two case reports. J Korean Neurosurg Soc. 2009;45(2):118–121. doi: 10.3340/jkns.2009.45.2.118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Shrestha R, Bishokarma S, Rayamajhi S, et al. Pituitary apoplexy presenting as isolated third cranial nerve palsy: case series. J Surg Case Rep. 2022;2022(8):rjac386. doi: 10.1093/jscr/rjac386 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Decker R, Pearson-Shaver AL. Uncal Herniation. In: StatPearls [Internet]. StatPearls Publishing; 2025. [Google Scholar]
- 26.Modi P, Arsiwalla T. Cranial Nerve III Palsy. In: StatPearls [Internet]. StatPearls Publishing; 2025. [Google Scholar]
- 27.Bergsneider M, Mirsadraei L, Yong WH, et al. The pituitary stalk effect: is it a passing phenomenon? J Neurooncol. 2014;117(3):477–484. doi: 10.1007/s11060-014-1386-5 [DOI] [PubMed] [Google Scholar]
- 28.Kruse A, Astrup J, Gyldensted C, Cold GE. Hyperprolactinaemia in patients with pituitary adenomas: the pituitary stalk compression syndrome. Br J Neurosurg. 1995;9(4):453–457. doi: 10.1080/02688699550041089 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated or analyzed during this study are included in this published article.
